Cytogenetic Evolution in a Patient with Chronic developing a Secondary Acute Myelogenous Leukemia Subtype M5 Resistant to Imatinib Mesylate Therapy

Walid AL Achkar^1*, Faten Moassass¹, Adnan Ikhtiar², Moneeb AK Othman³, Thomas Liehr³ and Abdulsamad Wafa¹

¹Human Genetics Division, Flow-cytometry Laboratory, Department of Molecular Biology and Biotechnology, Atomic Energy Commission of Syria, Damascus, Syria

²Mammalians Biology Division, Flow-cytometry Laboratory, Department of Molecular Biology and Biotechnology, Atomic Energy Commission of Syria, Damascus, Syria

³Jena University Hospital, Institute of Human Genetics, Jena, Germany

^*Corresponding Author: Walid AL Achkar, Human Genetics Division, Department of Molecular Biology and Biotechnology, Atomic Energy Commission of Syria, 17th Nissan St., Kafersouseh, Damascus, 6091, Syria, Tel: 963-11-2132580, Fax: 963- 11-6112289 Email: ,